Program

Time Table

Program DetailsTop of Page

JSN - GRT Joint Open SymposiumTop of Page

June 21(Sunday)17:00~19:00 Room A(1F/King)
Adult Neurogenesis and New Strategies for CNS Regeneration

[Chairs]
Hideyuki Okano (Department of Physiology, Keio University School of Medicine)
Toru Itakura (Department of Neurological Surgery, Wakayama Medical University)
[Speakers]
  • OS-1 Hippocampal neurogenesis and neural repair
    Tatsuhiro Hisatsune (Dept Integrated Biosciecnces, Univ of Tokyo)
  • OS-2 Cytoskeletal maturation and radiosensitivity of newly-generated neurons in the adult brain
    Tomoaki Shirao (Department of Neurobiology and Behavior, Gunma University Graduate School of Medicine)
  • OS-3 Neural cell differentiation plasticity regulated by methyl-CpG binding proteins
    Kinichi Nakashima (Lab. Mol. Neurosci., Grad. Sch. Biol. Sci., Nara Inst. Sci. Tech.)
  • OS-4 Decreased neurogenesis as a risk factor for mental diseases
    Noriko Osumi (Tohoku University Graduate School of Medicine)

ISN Symposium <in English>Top of Page

June 22(Monday)9:00~11:40 Room A(1F/King)
Axon Homeostasis and Diseases

[Chairs]
Hiroshi Kiyama (Department of Anatomy & Neurobiology, Osaka City University Graduate School of Medicine)
Katsuhiko Mikoshiba (Laboratory for Developmental Neurobiology, RIKEN Brain Science Institute)
[Speakers]
  • ISN-1 Molecular regulation of Wallerian degeneration of axons
    Michael Coleman (The Babraham Institute, Cambridge, UK)
  • ISN-2 Axon formation and polarized transport
    Kozo Kaibuchi (Nagoya University Graduate School of Medicine)
  • ISN-3 Control of axonal mitochondrial mobility and its impact on axonal homeostasis and degeneration
    Zu-Hang Sheng (NINDS, NIH, USA)
  • ISN-4 Transport and assembly dynamics of axonal neurofilaments
    Anthony Brown (Center for Molecular Neurobiology and Department of Neuroscience, Ohio State University, Columbus, USA)

ISN symposium (Summary) [PDF]

JSN - JSBP Joint Symposium <in English>Top of Page

June 23(Tuesday)9:00~11:40 Room A(1F/King)
Clues to the pathophysiology and treatment of psychiatric disorders through integrating neurochemistry and psychiatry

[Chairs]
Kazuhiro Ikenaka (Department of Molecular Physiology, National Institute for Physiological Sciences)
Toshikazu Saito (Department of Neuropsychiatry, School of Medicine, Sapporo Medical University)
Masahiko Mikuni (Department of Psychiatry and Human Behavior, Gunma University Graduate School of Medicine)
[Speakers]
  • JSN-JSBP-1 Peripheral cytokine level change in the pathophysiology of psychiatric disorders
    Wataru Ukai (Dept. of Neuropsychiatry, Sapporo Medical University, Sapporo, Japan)
  • JSN-JSBP-2 Antidepressive-like effect of continuous inhibition of GSK3β through region-specific neuroprotective effect
    Naoto Omata (Department of Neuropsychiatry, University of Fukui, Fukui, Japan, Molecular Neurobiology Section, NIMH, NIH, Bethesda, USA)
  • JSN-JSBP-3 Identification of susceptibility genes for mental disorders using Intermediate phenotype
    Ryota Hashimoto (The Osaka-Hamamatsu Joint Research Center For Child Mental Development, Osaka University Graduate School of Medicine, Suita, Japan, Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan)
  • JSN-JSBP-4 Function of EGF receptor signaling in the neonatal hippocampal lesion model of schizophrenia
    Makoto Mizuno (Center for Transdisciplinary Research, Niigata Univ, Mol Neurobiol, Brain Res Inst, Niigata Univ)
  • JSN-JSBP-5 Neural correlates of sexually-dimorphic social behavior and social dysfunction in subjects with autism
    Hidenori Yamasue (Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, JAPAN)
  • JSN-JSBP-6 PACAP regulates the neural extension in adult neurogenesis
    Kohei Yamada (Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Osaka, Japan)

Young Scientists Lectureship Award
Symposium <in English>Top of Page

June 22(Monday)14:20~15:50 Room A(1F/King)

[Chairs]
Yukio Yoneda (Laboratory of Molecular Pharmacology, Kanazawa University Graduate School of Natural Science and Technology)
Hiroshi Kiyama (Department of Anatomy & Neurobiology, Osaka City University Graduate School of Medicine)
[Speaker]
  • LA-1 Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered glutamate release
    Tadahiro Numakawa (Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry)

SymposiaTop of Page

Symposium1

June 22(Monday)9:00~11:40 Room B(9F/Amanogawa)
New insights into astrocytogenesis in the mammalian central nervous system

[Chairs]
Yasuki Ishizaki (Department of Molecular and Cellular Neurobiology, Gunma University Graduate School of Medicine)
Kinichi Nakashima (Laboratory of Molecular Neuroscience, Graduate School of Biological Sciences, Nara Institute of Science and Technology)
[Speakers]
  • S01-1 Olig2 progenitor cells preferentially differentiate to astrocytes in response to various stimuli in the gray matter of adult forebrain
    Kouko Tatsumi (The Department of Anatomy, Nara Medical University, Nara, Japan)
  • S01-2 BMPR1A and BMPR1B differentially regulate gliosis
    Masahisa Yamada (RIKEN Brain Science Institute, Yamada Research Unit)
  • S01-3 Astrocyte precursor cells in the developing mouse cerebellum
    Masashi Kurachi (Department of Molecular and Cellular Neurobiology, Gunma University Graduate School of Medicine, Maebashi, Japan)
  • S01-4 Glial cell sub-lineages in the developing central nervous system
    Tetsushi Kagawa (Dept. of stem cell regulation, Med. Res. Inst., Tokyo Med. and Dent. Univ.)
  • S01-5 Mechanism in sequential differentiation of neural stem cells
    Kinichi Nakashima (Lab. Mol. Neurosci., Grad. Sch. Biol. Sci., Nara Inst. Sci. Tech.)
  • S01-6 The role of neurogenesis-regulating transcription factor Pax6 in astroglial development
    Noriko Osumi (Tohoku University Graduate School of Medicine)

Symposium2

June 22(Monday)9:00~11:40 Room C(3F/Eboshi)
The challenge of epigenetics to elucidate the cause of mental disorders

[Chairs]
Kohji Fukunaga (Graduate School of Pharmaceutical Sciences, Tohoku University)
Takeo Kubota (Department of Epigenetic Medicine, University of Yamanashi)
[Speakers]
  • S02-1 Role of DNA methylation in mental disorders
    Tadafumi Kato (Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute)
  • S02-2 DNA demethylation and spatial gene positioning of an astrocyte specific gene, GFAP
    Takumi Takizawa (Lab. of Molecular Neuroscience, Grad. School of Biological Sciences, NAIST)
  • S02-3 The mechanism of abnormal dendritic spine formation in chromatin remodeling factor ATRX mutant mice
    Norifumi Shioda (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan)
  • S02-4 The Role of Epigenetic Modifier for Neuronal Differentiation during Retinogenesis
    Itsuki Ajioka (KANRINMARU-project, Keio U Sch Med, Tokyo, Japan, Dept of Anatomy, Keio U Sch Med, Tokyo, Japan, Dept of Developmental Neurobiology, St Jude Childrens Res Hosp, Memphis, TN, USA)
  • S02-5 Epigenetics in autistic diseases
    Takeo Kubota (Dept. Epigenetic Med., Univ. of Yamanashi)

Symposium3

June 22(Monday)9:00~11:40 Room D(1F/Nagamine)
Update of autism and other developmental disorders, basic and clinic

[Chairs]
Masaaki Narita (School of Medicine, Mie University)
Masatoshi Takeda (Department of Psychiatry, Osaka University Graduate School of Medicine)
[Speakers]
  • S03-1 Update of autism model animals
    Masaaki Narita (Mie University School of Medicine)
  • S03-2 Alterations in the expression of gene and protein in ADHD model rats
    Yoshinori Masuo (Mental Stress Team, Health Technology Research Center, National Institute of Advanced Industrial Science and Technology (AIST))
  • S03-3 Impaired prefrontal cortical response by switching stimuli in autism spectrum disorders assessed by near-infrared spectroscopy
    Naoko Narita (Dept. of Education, Bunkyo University)
  • S03-4 A perspective of biological marker research for Autism
    Hideo Matsuzaki (Osaka Univ Graduate School of Child Development, Suita, Japan, 2 Dept of Psychiatry and Neurology, Hamamatsu Univ School of Med)
  • S03-5 Neonatal exposure to excess neuregulin-1 signaling alters the dopaminergic function
    Taisuke Kato (Mol .Neurobiol. Brain Res. Inst. Niigata Univ., Niigata)
  • S03-6 Maternal infection affects neurogenesis in the developing cerebral cortex
    Hitomi Soumiya (Laboratory of Molecular Biology, Department of Biofunctional analysis, Gifu Pharmaceutical University, Gifu, Japan)

Symposium4 <in English>

June 23(Tuesday)9:00~11:40 Room B(9F/Amanogawa)
Novel insights into the roles of protein kinases in synaptic plasticity and memory

[Chairs]
Shin-ichi Hisanaga (Molecular Neuroscience Laboratory, Department of Biological Sciences, Tokyo Metropolitan University)
Satoshi Kida (Department of Bioscience, Tokyo University of Agriculture)
[Speakers]
  • S04-1 The function of neuronal activity-dependent CaMKII activation in synaptic plasticity
    Kohji Fukunaga (Dept. Pharmacol., Tohoku Univ. Grad. Sch. Pharm. Scis. and COE program "CRESCENDO")
  • S04-2 Roles of CaMKIV Signaling Pathway in Memory Formation
    Satoshi Kida (Tokyo University of Agriculture)
  • S04-3 Memory improvement by inhibiting PKA in Drosophila
    Junjiro Horiuchi (Laboratory of Cellular Genetics, Tokyo Metropolitan University)
  • S04-4 mTOR kinase signaling in learning paradigm
    Nobuyuki Takei (Brain Research Institute, Niigata University)
  • S04-5 Glycogen synthase kinase 3 (GSK3) in synaptic plasticity, learning & memory
    Florian Plattner (Institute of Neurology, University College London)
  • S04-6 CDK5 AND SYNAPTIC PLASTICITY
    James Bibb (Department of Psychiatry, The University of Texas Southwestern Medical Center)

Symposium5

June 23(Tuesday)9:00~11:40 Room C(3F/Eboshi)
Translational research between basic science and drug discovery

[Chairs]
Shinichi Koizumi (RaQualia Pharma Inc.)
Shinichi Kohsaka (National Institute of Neuroscience, National Center of Neurology and Psychiatry)
[Panelists]
Takashi Tsukamoto (Johns Hopkins University)
Yoshitaka Nagai (Department of Degenerative Neurological Diseases, National Institute of Neuroscience)
Atsumi Nitta (Department of Neuropsyachopharmacology and Hospital Pharmacy Nagoya University Graduate School of Medicine)
[Speakers]
  • S05-1 Drug discovery research as a translation of science to drug candidates
    Shinichi Koizumi (RaQualia Pharma Inc. Aichi, Japan)
  • S05-2 A novel computational approach for drug discovery : Chemical genomics-based in silico ligand screening
    Yasushi Okuno (Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan)
  • S05-3 How to translate "chemical compounds" into "medicines" for the use of disease treatments
    Toshinori Yamamoto (RaQualia Pharma Inc.)

Symposium6 <in English>

June 23(Tuesday)9:00~11:40 Room D(1F/Nagamine)
Regulation of cell migration and axon guidance

[Chairs]
Yoshio Goshima (Department of Molecular Pharmacology and Neurobiology, Graduate School of Medicine, Yokohama City University)
Kazunori Nakajima (Department of Anatomy, Keio University School of Medicine)
[Speakers]
  • S06-1 Abi2 plays an essential role for radial migration in the developing cerebral cortex via WAVE2-Arp 2/3 complex
    Min-Jue Xie (Division of Cell Biology and Neuroscience, Department of Morphological and Physiological Sciences, Faculty of Medical Sciences, University of Fukui, Fukui)
  • S06-2 Reelin-Dab1 signal regulates the local inside-out lamination through terminal translocation
    Katsutoshi Sekine (Department of Anatomy, Keio University School of Medicine, Tokyo, Japan)
  • S06-3 Slit-Robo signaling regulates migration of newly-born neurons under physiological and pathological conditions in the postnatal brain
    Naoko Kaneko (Department of Developmental and Regenerative Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan)
  • S06-4 A novel repulsive guidance protein, Draxin
    Hideaki Tanaka (Division of Developmental Neurobiology, Kumamoto University, Global COE "Cell Fate Regulation Research and Education Unit", Kumamoto University)
  • S06-5 Cellular functions of a novel axon guidance molecule LOTUS
    Kohtaro Takei (Department of Molecular Pharmacology and Neurobiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan)
  • S06-6 Regulation of axon outgrowth by new positive feedback mechanisms through membrane stretch activated channel
    Koji Shibasaki (Section of Cell Signaling, Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences, National Institute for Physiological Sciences, Department of Physiological Sciences, The Graduate University for Advanced Studies)

Symposium7

June 23(Tuesday)15:50~18:30 Room A(1F/King)
Integrative advance of neurology and psychiatry

[Chairs]
Keiji Wada (Department of Degenerative Neurological Diseases, National Institute of Neuroscience)
Toru Nishikawa (Section of Psychiatry and Behavioral Sciences, Tokyo Medical and Dental University)
[Speakers]
  • S07-1 Neuronal cell dysfunction as a common pathophysiology of neurological and psychiatric disorders
    Akira Sawa (Program in Molecular Psychiatry, Departments of Psychiatry and Neuroscience, Johns Hopkins University School of Medicine)
  • S07-2 Experience dependent synaptic delivery of AMPA receptors
    Takuya Takahashi (Dept of Physiol., Yokohama City Univ. Grad. Sch. Med., Yokohama, Japan)
  • S07-3 The brain as the center for the integration of biological information
    Keiji Wada (Natl Inst Neurosci, NCNP, Tokyo, Japan, CREST, JST, Kawaguchi, Saitama, Japan)
  • S07-4 From a Neurologist
    Miho Murata (Dept. Neurology, National Center Hospital of Neurology & Psychiatry, Tokyo, Japan)
  • S07-5 Integrated approaches of psychiatry and neurology; from a clinical psychiatry perspective
    Akira Sano (Department of Psychiatry, Kagoshima University Graduateschool of Medical and Dental Sciences, Kagoshima, Japan)

Symposium8 <in English>

June 23(Tuesday)15:50~18:30 Room B(9F/Amanogawa)
Quality controls of proteins and neuropsychiatric diseases

[Chairs]
Takashi Kudo (Department of Psychiatry, Osaka University Graduate School of Medicine)
Kazunori Imaizumi (Division of Molecular and Cellular Biology, University of Miyazaki)
[Speakers]
  • S08-1 Role of chronic ER stress in neurodegeneration and bipolar disorder
    Fumihiko Urano (University of Massachusetts Medical School, Worcester, Massachusetts, U.S.A.)
  • S08-2 Cellular dysfunction associated with Aβ oligomers enhanced by APP E693Δ mutation
    Takami Tomiyama (Department of Neuroscience, Osaka City University Graduate School of Medicine, Osaka, Japan)
  • S08-3 Mechanism of tau aggregation mediated neurodegeneration
    Akihiko Takashima (Laboratory for Alzheimer's Disease, RIKEN, Brain science Institute, Wako, Japan)
  • S08-4 The involvement of ER stress in pathogenesis after cerebral ischemia
    Hideaki Hara (Gifu Pharmaceutical Uni., Gifu, JAPAN)
  • S08-5 Novel therapeutic strategies for neurodegerative diseases based on ERproteasome system
    Takashi Kudo (Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan)

Symposium9

June 23(Tuesday)15:50~18:30 Room C(3F/Eboshi)
New vistas of neurochemistry using the large-scale genome-wide analysis : -omics approaches

[Chairs]
Michihiro Igarashi (Graduate School of Medical and Dental Sciences, Niigata University)
Yoshio Hirabayashi (Hirabayashi Research Unit, RIKEN Brain Science Institute)
[Speakers]
  • S09-1 Cerebellar Development Transcriptome Analysis: Towards the elucidation of the genetic basis of cerebellar circuit development
    Kanehiro Hayashi (Lab for Molecular Neurogenesis, RIKEN BSI)
  • S09-2 Synaptic function regulated by palmitoylating enzyme family
    Masaki Fukata (Division of Membrane Physiology, National Institut e for Physiological Sciences, PRESTO, JST)
  • S09-3 Strategy for the Growth Cone Research using Proteomics
    Michihiro Igarashi (Niigata Univ Grad Sch Med Dent Sci, Niigata, Japan)
  • S09-4 Lipidomics for neurochemistry - basic techniques and strategy
    Ryo Taguchi (Dept. of Metabolome, Med, Univ. of Tokyo)
  • S09-5 Mass spectrometric analysis of minor components in brain -phosphorylated proteins and membrane lipids
    Yoshio Hirabayashi (RIKEN Brain Science Institute)

Symposium10 <in English>

June 23(Tuesday)15:50~18:30 Room D(1F/Nagamine)
Dynamics and functions of cytoskeletal- and membrane-proteins in neuronal growth cones and dendritic spines

[Chairs]
Ryoki Ishikawa (Department of Molecular and Cellular Pharmacology, Gunma University Graduate School of Medicine)
Tatsuo Suzuki (Department of Neuroplasticity, Shinshu University Graduate School of Medicine)
[Speakers]
  • S10-1 Dynamics of Actin binding proteins observed in living growth cones
    Kaoru Katoh (Neurosci. Res. Inst., AIST, Tsukuba, Japan)
  • S10-2 Drebrin-mediated actin-linked control of actomyosin system at the transitional zone plays a pivotal role in axonal growth
    Kenji Hanamura (Dept Neurobiology and Behavior, Gunma Univ. Grad Sch of Med,)
  • S10-3 Role of cofilin phosphorylation in BDNF-induced dendritogenesis
    Kazumasa Ohashi (Grad. Sch. of Life Sci., Tohoku Univ., Sendai)
  • S10-4 Dynamics of fascin, cofilin, and drebrin in growth cones: comparison with the results obtained by in vitro analysis
    Ryoki Ishikawa (Dept. Mol. Cell. Pharmacol., Gunma Univ. Grad. Sch. Med.)
  • S10-5 Electron tomographic reconstruction of clathrin coated endocytic intermediates in nerve terminals that lack dynamin 1
    Mitsuko Hayashi-Nishino (Dept. of Cell Memb. Biol., ISIR, Osaka Univ., Dept. of Cell Biol./HHMI, Yale Univ. Shool of Med.)
  • S10-6 The role of microtubules for synaptic plasticity
    Fuyuki Mitsuyama (Dept. of Neurosurgery, Univ. of Fujita-Health Univ. Japan)

Symposium11

June 24(Wednesday)13:10~15:50 Room A(1F/King)
Physiological and pathological functions of microglia : current knowledge and future directions

[Chairs]
Hiroshi Nakanishi (Department of Aging and Pharmacological Sciences, Faculty of Dental Sciences, Kyushu University)
Kazuhide Inoue (Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University)
[Speakers]
  • S11-1 Chemotactic response of micoglia to brain injury; molecular mechanisms of microglial migration and process extension induced by extracellular ATP
    Keiko Ohsawa (Dept. of Neurochem., Natl. Inst. of Neurosci.)
  • S11-2 Microglia and pathological pain
    Makoto Tsuda (Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan)
  • S11-3 Engulfment of axon debris by microglia requires p38 MAPK activity
    Tatsuhide Tanaka (Dept. of Mol. Neurosci., Grad. Sch. of Med., Osaka Univ.)
  • S11-4 Microglia-aging: Roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging
    Hiroshi Nakanishi (Laboratory of Oral Aging Science, Faculty of Dental Sciences, Kyshu University)
  • S11-5 The Involvement of Glial Reaction with Peripheral Benzodiazepine Receptor as Biomarker and Functional Molecule in Pathological Development of Alzheimers disease
    Bin Ji (National Institute of Radiological Sciences, Chiba, Japan)

Symposium12

June 24(Wednesday)13:10~15:50 Room B(9F/Amanogawa)
Translational research for psychiatric, neurological, neuromuscular diseases

[Chairs]
Ryota Hashimoto (The Osaka-Hamamatsu Joint Research Center for Child Mental Development, Osaka University Graduate School of Medicine)
Shoji Tsuji (Department of Neurology, Graduate School of Medicine, The University of Tokyo)
[Speakers]
  • S12-1 Translational research in psychiatry: dysbindin and schizophrenia
    Ryota Hashimoto (The Osaka-Hamamatsu Joint Research Center for Child Mental Development, Osaka University Graduate School of Medicine, Department of Psychiatry, Osaka University Graduate School of Medicine)
  • S12-2 Social isolated dominant-negative Disrupted-in-Schizophrenia-1 transgenic mice is useful for a novel animal model of schizophrenia and mood disorders
    Minae Niwa (Psychiatry, Nagoya Univ Grad Sch Med, Nagoya, Chem Pharmacol, Meijo Univ Grad Sch Pharmacal Sci, Nagoya)
  • S12-3 Aberrant A-to-I RNA editing and ALS
    Shin Kwak (Dept. of Neurol., Grad. School. of Med., Univ. of Tokyo, Tokyo, Japan)
  • S12-4 Na+/Ca2+ exchanger mediates dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease
    Tetsuaki Nashida (Lab. Medicinal Pharmacol., Grad. Sch. Pharmaceut. Sci., Osaka Univ, Osaka, Japan)
  • S12-5 Glycosylation abnormality and muscular dystrophy -pathomechanism and therapeutic strategy
    Tatsushi Toda (Div. of Neurol. & Molec. Neurosci., Kobe Univ. Grad. Schl. Med.)
  • S12-6 Progress in translational research of muscular dystrophy (from lab bench to bedside)
    Shin'ichi Takeda (Department of Molecular Therapy, National Institute of Neuroscience, NCNP)

Symposium13

June 24(Wednesday)13:10~15:50 Room C(3F/Eboshi)
Recent progress and perspective of primate models for psychiatric diseases

[Chairs]
Katsuki Nakamura (Primate Research Institute, Kyoto University)
Hiroyuki Nawa (Division of Neurobiology, Brain Research Institute, Niigata University)
[Speakers]
  • S13-1 Neural mechanisms of social behaviors in primates
    Hisao Nishijo (System Emotional Science, CREST, JST)
  • S13-2 Methods for assessing marmoset behavior
    Katsuki Nakamura (Primate Research Institute, Kyoto University, National Institute of Neuroscience, National Center of Neurology and Psychiatry)
  • S13-3 Schizophrenia animal models established with ErbB receptor ligands
    Hiroyuki Nawa (Mol Neurobiol, Brain Res Inst, Niigata Univ, Trans Res, Niigata Univ,)
  • S13-4 Application of recombinant viral vectors to primate brain research: Gene therapy for Parkinson disease
    Masahiko Takada (Systems Neuroscience Section, Department of Cellular and Molecular Biology, Primate Research Institute, Kyoto University, Kyoto, Japan)
  • S13-5 Towards generation of transgenic nonhuman primates
    Erika Sasaki (Marmsoet Research Department, Central Institute for Experimental Animals)

Symposium14

June 24(Wednesday)13:10~15:50 Room D(1F/Nagamine)
Frontiers in understanding neuronal communication

[Chairs]
Yuko Sekino (Division of Neuronal Network, Institute of Medical Science, University of Tokyo)
Konosuke Kumakura (Department of Information and Communication Sciences, Sophia University)
[Speakers]
  • S14-1 Molecular structure underlying neurotransmitter release from the active zone
    Toshihisa Ohtsuka (Dep. of Mol. Patho., Univ. of Toyama)
  • S14-2 Imaging of excitatory and inhibitory synaptic responses in the lateral amygdale using a voltage sensitive dye
    Yuko Sekino (Div. of Neuronal Network, Inst.Med.Sci., University of Tokyo, Tokyo, Japan, CREST, JST, Saitama, Japan)
  • S14-3 Glutamate release visualized with glutamate optical sensor
    Kenzo Hirose (Department of Neurobiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan)
  • S14-4 GABA imaging and transient GABA distribution in the developing cerebellar cortex
    Sachiko Yoshida (Department of Material Science., Toyohashi University of Technology, Toyohashi, Japan)
  • S14-5 Imaging Activity-Dependent Secretion of BDNF
    Naoto Matsuda (NIPS, University of California, Berkeley)

Luncheon SeminarsTop of Page

Luncheon Seminar1 Sponsor : Janssen Pharmaceutical K.K.

June 23(Tuesday)12:00~13:00 Room A(1F/King)

[Chair]
Masahiko Mikuni, MD/PhD (Department of Psychiatry and Human Behavior, Gunma University Graduate School of Medicine)
[Speaker]
"Pathophysiological hypotheses and pharmacological interventions for schizophrenia"
Takashi Kudo, MD/PhD (Department of Psychiatry, Osaka University Graduate School of Medicine)

Luncheon Seminar2 Sponsor : Applied Biosystems Japan Ltd.

June 23(Tuesday)12:00~13:00 Room C(3F/Eboshi)

[Chair]
Takehiko Okada (Applied Biosystems Japan Ltd.)
[Speakers]
  • 1. "Introduction of the novel tool for dynamic analysis of the phosphoproteins and determination of their phosphorylation sites"
    Takuichi Tsubata, PhD (Applied Biosystems Japan Ltd.)
  • 2. "Phosphoprotemic analysis of the growth cone and the synaptosomes : Novel findings in neuronal growth and synaptic transmission"
    Michihiro Igarashi, MD/PhD (Graduate School of Medical and Dental Sciences, Niigata University)

Luncheon Seminar3 Sponsor : Mitsubishi Tanabe Pharma Corporation / Yoshitomiyakuhin Corporation

June 24(Wednesday)12:00~13:00 Room B(9F/Amanogawa)

[Chair]
Masahiko Mikuni, MD/PhD (Department of Psychiatry and Human Behavior, Gunma University Graduate School of Medicine)
[Speaker]
"How can we select the most appropriate second generation antipsychotics based on the mechanisms of action?"
Ichiro Kusumi, MD/PhD (Department of Psychiatry, Hokkaido University Graduate School of Medicine)

Top of Page